The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of pevonedistat (P) + azacitidine (A) versus A in patients (pts) with higher-risk myelodysplastic syndromes (MDS)/chronic myelomonocytic leukemia (CMML), or low-blast acute myelogenous leukemia (LB AML) (NCT02610777).
 
Lionel Ades
Consulting or Advisory Role - Celgene; Takeda
Research Funding - Celgene
Travel, Accommodations, Expenses - Abbvie; Takeda
 
Justin M. Watts
Consulting or Advisory Role - Celgene; Jazz Pharmaceuticals; Pfizer
Speakers' Bureau - Jazz Pharmaceuticals
Research Funding - Takeda
 
Atanas Radinoff
Honoraria - Janssen; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Janssen; Novartis; Pfizer; SERVIER
Research Funding - Amgen; Bayer; Takeda
Travel, Accommodations, Expenses - Acraf; Amgen; Takeda
 
Montserrat Arnan
Consulting or Advisory Role - Celgene; Novartis
Speakers' Bureau - Celgene; Novartis
 
Marco Cerrano
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Jazz Pharmaceuticals
 
Patricia Font Lopez
Consulting or Advisory Role - Celgene; Novartis; Pfizer
Speakers' Bureau - Celgene; Novartis
Travel, Accommodations, Expenses - Abbvie; Celgene; Novartis
 
Joshua F. Zeidner
Consulting or Advisory Role - Abbvie; Agios; Asystbio Laboratories; Celgene; Daiichi Sankyo; Genentech; Pfizer; Takeda; Tolero Pharmaceuticals
Research Funding - Celgene (Inst); Merck (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Agios; Celgene; Daiichi Sankyo; Dava Oncology; Forty Seven; Takeda; Tolero Pharmaceuticals
 
Maria Diez-Campelo
No Relationships to Disclose
 
Carlos Graux
Consulting or Advisory Role - Amgen; ARIAD; Celgene; Janssen; Pfizer
 
Jane Liesveld
Consulting or Advisory Role - Abbvie; Onconova Therapeutics
 
Dominik Selleslag
Honoraria - Abbvie; Alexion Pharmaceuticals; Amgen; Celgene; GlaxoSmithKline; Incyte; Janssen-Cilag; MSD; Novartis; Pfizer; Sanofi; Takeda; Teva
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Amgen; Celgene; GlaxoSmithKline; Incyte; Janssen-Cilag; MSD; Novartis; Pfizer; Sanofi; Takeda; Teva
Speakers' Bureau - Amgen; Celgene; MSD; Novartis; Takeda; Teva
(OPTIONAL) Uncompensated Relationships - Belgian college for reimbursement of orphan drugs
 
Nikolay Tzvetkov
No Relationships to Disclose
 
Robert J. Fram
Employment - Takeda
Stock and Other Ownership Interests - Baxter; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Pfizer; Takeda; Teva
Consulting or Advisory Role - BeyondSpring Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Vertex
Travel, Accommodations, Expenses - Takeda
 
Dan Zhao
Employment - Takeda
 
Douglas V. Faller
Employment - Takeda
Leadership - Viracta Therapeutics
Stock and Other Ownership Interests - Viracta Therapeutics
Patents, Royalties, Other Intellectual Property - Viracta Therapeutics
 
Mikkael A. Sekeres
Consulting or Advisory Role - Celgene; Millennium; Syros Pharmaceuticals
Research Funding - Pfizer (Inst); Takeda (Inst)